Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
YNBY International Ltd. operates as an investment holding company, conducting business primarily in money lending and the global trade of various goods and commodities across Hong Kong, the People's Republic of China, and international territories. The firm's operations are divided into distinct segments: Money Lending, Trading of Goods and Commodities, and Cannabidiol (CBD) isolate. In its financial services arm, the company offers short-term loans to both private individuals and corporate entities. Its trading activities encompass a diverse portfolio, including refined edible oil, sugar, cosmetics, cannabidiol, and personal care products. Moreover, YNBY International has established a strategic partnership with Alpex Pharma SA to jointly advance the development and commercialization of nutraceuticals. Located in Wan Chai, Hong Kong, the company adopted its current name after previously operating as ABC Communications (Holdings) Limited and subsequently as Ban Loong Holdings Limited, a change that occurred in October 2015.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA